Paper20111697
ACE2 activation promotes antithrombotic activity.
Fraga-Silva RA and 10 others. Mol Med, 2010. Cited by 112 papers, by iCite.
Cite this record
ConductScience Library. ACE2 activation promotes antithrombotic activity. Papers, record 20111697. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20111697
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Peptidyl-Dipeptidase A | Major topic |
| Thrombosis | Major topic |
| Analysis of Variance | |
| Angiotensin-Converting Enzyme 2 | |
| Animals | |
| Male | |
| Mice | |
| Mice, Nude | |
| Rats | |
| Rats, Inbred SHR | |
| Rats, Inbred WKY | |
| Xanthones |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 HL056921 | NHLBI NIH HHS | United States | R01HL056921 | PubMed and NIH | NIH RePORTER |
| 56912 | PHS HHS | United States | PubMed | PubMed |
References28
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11881036 | The antithrombotic effect of angiotensin-(1-7) closely resembles that of losartan. | J Renin Angiotensin Aldosterone Syst | 2000 | https://conductscience.org/library/papers/11881036 | PubMed |
| 2 | 16420573 | Murine model of ferric chloride-induced vena cava thrombosis: evidence for effect of potato carboxypeptidase inhibitor. | J Thromb Haemost | 2006 | https://conductscience.org/library/papers/16420573 | PubMed |
| 3 | 16178638 | Hyperspectral imaging of hemoglobin saturation in tumor microvasculature and tumor hypoxia development. | J Biomed Opt | 2005 | https://conductscience.org/library/papers/16178638 | PubMed |
| 4 | 8026020 | Angiotensin II increases plasminogen activator inhibitor type 1 and tissue-type plasminogen activator messenger RNA in cultured rat aortic smooth muscle cells. | Circulation | 1994 | https://conductscience.org/library/papers/8026020 | PubMed |
| 5 | 10980590 | Angiotensin II can induce and potentiate shape change in human platelets: effect of losartan. | J Hum Hypertens | 2000 | https://conductscience.org/library/papers/10980590 | PubMed |
| 6 | 12829792 | Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. | Proc Natl Acad Sci U S A | 2003 | https://conductscience.org/library/papers/12829792 | PubMed |
| 7 | 12411476 | Antithrombotic effect of captopril and losartan is mediated by angiotensin-(1-7). | Hypertension | 2002 | https://conductscience.org/library/papers/12411476 | PubMed |
| 8 | 19340108 | Multimodal optical imaging of microvessel network convective oxygen transport dynamics. | Appl Opt | 2009 | https://conductscience.org/library/papers/19340108 | PubMed |
| 9 | 12364357 | Angiotensin II AT1 receptor antagonists inhibit platelet adhesion and aggregation by nitric oxide release. | Hypertension | 2002 | https://conductscience.org/library/papers/12364357 | PubMed |
| 10 | 18026570 | The antithrombotic effect of angiotensin-(1-7) involves mas-mediated NO release from platelets. | Mol Med | 2008 | https://conductscience.org/library/papers/18026570 | PubMed |
| 11 | 18520721 | Genomic and proteomic approaches for targeting of angiotensin-converting enzyme2 for cardiovascular diseases. | Curr Opin Cardiol | 2008 | https://conductscience.org/library/papers/18520721 | PubMed |
| 12 | 19246717 | Evidence for angiotensin-converting enzyme 2 as a therapeutic target for the prevention of pulmonary hypertension. | Am J Respir Crit Care Med | 2009 | https://conductscience.org/library/papers/19246717 | PubMed |
| 13 | 12075344 | Angiotensin-converting enzyme 2 is an essential regulator of heart function. | Nature | 2002 | https://conductscience.org/library/papers/12075344 | PubMed |
| 14 | 11815627 | Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. | J Biol Chem | 2002 | https://conductscience.org/library/papers/11815627 | PubMed |
| 15 | 9241756 | Angiotensin II increases plasminogen activator inhibitor-1 and tissue factor mRNA expression without changing that of tissue type plasminogen activator or tissue factor pathway inhibitor in cultured rat aortic endothelial cells. | Thromb Haemost | 1997 | https://conductscience.org/library/papers/9241756 | PubMed |
| 16 | 18391097 | Structure-based identification of small-molecule angiotensin-converting enzyme 2 activators as novel antihypertensive agents. | Hypertension | 2008 | https://conductscience.org/library/papers/18391097 | PubMed |
| 17 | 15326087 | Nonpeptide AVE 0991 is an angiotensin-(1-7) receptor Mas agonist in the mouse kidney. | Hypertension | 2004 | https://conductscience.org/library/papers/15326087 | PubMed |
| 18 | 10969042 | A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. | Circ Res | 2000 | https://conductscience.org/library/papers/10969042 | PubMed |
| 19 | 15380922 | Cloning and characterization of a secreted form of angiotensin-converting enzyme 2. | Regul Pept | 2004 | https://conductscience.org/library/papers/15380922 | PubMed |
| 20 | 17651844 | Late ventricular remodeling in non-reperfused acute myocardial infarction in humans is predicted by angiotensin II type 1 receptor density on blood platelets. | Int J Cardiol | 2008 | https://conductscience.org/library/papers/17651844 | PubMed |
Cited by92
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 112 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42875448 | Angiotensin II exacerbates intracerebral hemorrhage in mice via heparin-like antithrombin activation and coagulation dysfunction. | Nat Commun | 2026 | https://conductscience.org/library/papers/42875448 | PubMed |
| 41828989 | Understanding Pathophysiological Complexity of Feline Hypertrophic Cardiomyopathy Using SWATH-MS Plasma Proteomics. | Animals (Basel) | 2026 | https://conductscience.org/library/papers/41828989 | PubMed |
| 40129927 | Therapeutic effects of exosomes from angiotensin-converting enzyme 2 - overexpressed endothelial progenitor cells on intracerebral hemorrhagic stroke. | Brain Hemorrhages | 2021 | https://conductscience.org/library/papers/40129927 | PubMed |
| 39442286 | Thymidine phosphorylase mediates SARS-CoV-2 spike protein enhanced thrombosis in K18-hACE2TG mice. | Thromb Res | 2024 | https://conductscience.org/library/papers/39442286 | PubMed |
| 38863899 | The possible mechanism and research progress of ACE2 involved in cardiovascular injury caused by COVID-19: a review. | Front Cardiovasc Med | 2024 | https://conductscience.org/library/papers/38863899 | PubMed |
| 38652364 | Role of the RAAS in mediating the pathophysiology of COVID-19. | Pharmacol Rep | 2024 | https://conductscience.org/library/papers/38652364 | PubMed |
| 38474396 | Modulations of Homeostatic ACE2, CD147, GRP78 Pathways Correlate with Vascular and Endothelial Performance Markers during Pulmonary SARS-CoV-2 Infection. | Cells | 2024 | https://conductscience.org/library/papers/38474396 | PubMed |
| 37264452 | The controversial effect of smoking and nicotine in SARS-CoV-2 infection. | Allergy Asthma Clin Immunol | 2023 | https://conductscience.org/library/papers/37264452 | PubMed |
| 37208552 | Variant-derived SARS-CoV-2 spike protein does not directly cause platelet activation or hypercoagulability. | Clin Exp Med | 2023 | https://conductscience.org/library/papers/37208552 | PubMed |
| 37197279 | Role of Angiotensin Converting Enzyme-2 and its modulation in disease: exploring new frontiers. | Med Pharm Rep | 2023 | https://conductscience.org/library/papers/37197279 | PubMed |
| 37096378 | Pharmacologic Activation of Angiotensin-Converting Enzyme II Alleviates Diabetic Cardiomyopathy in db/db Mice by Reducing Reactive Oxidative Stress. | Diabetes Metab J | 2023 | https://conductscience.org/library/papers/37096378 | PubMed |
| 36481346 | Counter-regulatory renin-angiotensin system in hypertension: Review and update in the era of COVID-19 pandemic. | Biochem Pharmacol | 2023 | https://conductscience.org/library/papers/36481346 | PubMed |
| 35327504 | Association between COVID-19 Diagnosis and Coronary Artery Thrombosis: A Narrative Review. | Biomedicines | 2022 | https://conductscience.org/library/papers/35327504 | PubMed |
| 35157210 | SARS-CoV-2 interacts with renin-angiotensin system: impact on the central nervous system in elderly patients. | Geroscience | 2022 | https://conductscience.org/library/papers/35157210 | PubMed |
| 35053224 | Calcium Signaling Pathway Is Involved in the Shedding of ACE2 Catalytic Ectodomain: New Insights for Clinical and Therapeutic Applications of ACE2 for COVID-19. | Biomolecules | 2022 | https://conductscience.org/library/papers/35053224 | PubMed |
| 34884604 | Alternative RAS in Various Hypoxic Conditions: From Myocardial Infarction to COVID-19. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34884604 | PubMed |
| 34769350 | The Role of Endothelium in COVID-19. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34769350 | PubMed |
| 34740598 | Increased complications of COVID-19 in people with cardiovascular disease: Role of the renin-angiotensin-aldosterone system (RAAS) dysregulation. | Chem Biol Interact | 2022 | https://conductscience.org/library/papers/34740598 | PubMed |
| 34687279 | Rapid Detection and Inhibition of SARS-CoV-2-Spike Mutation-Mediated Microthrombosis. | Adv Sci (Weinh) | 2021 | https://conductscience.org/library/papers/34687279 | PubMed |
| 34667599 | Endothelial dysfunction and COVID-19 (Review). | Biomed Rep | 2021 | https://conductscience.org/library/papers/34667599 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ACE2 | 59272 | PubTator's text mining | https://conductscience.org/library/genes/59272 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20111697
GET https://conductscience.org/api/papers/v1/20111697/references?page=2